Overview
Total raised
$12.52M
Founded date
2016
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Nov 30, 2018 | Series A round | $6.38M |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 30, 2018 | IGEM Therapeutics Announces Final Close of £5m Series A Financing Round | IGEM Therapeutics (IGEM or “the Company”), an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer, announced it has secured an additional £3 million to close its Series A round at £5 million. Two new i... |
| Epsilogen | “Home - Epsilogen” |
Reviews 0
FAQ about IGEM Therapeutics
When was IGEM Therapeutics founded?
IGEM Therapeutics was founded in 2016.
How much funding has IGEM Therapeutics raised?
IGEM Therapeutics has raised $12.52M in total across 2 funding rounds.
What funding rounds has IGEM Therapeutics raised?
Parsers VC lists 2 funding rounds of IGEM Therapeutics, among them a Series A round of $6.38M on Nov 30, 2018.
What has the press written about IGEM Therapeutics?
Parsers VC has collected 3 articles mentioning IGEM Therapeutics, among them “IGEM Therapeutics Announces Final Close of £5m Series A Financing Round” (Nov 30, 2018) and “Epsilogen”.
Is IGEM Therapeutics still active?
IGEM Therapeutics is probably closed: its latest activity on Parsers VC dates from Aug 27, 2019.